METHODS: Twenty-two descriptive radiologic features were retrospectively evaluated on preoperative computed tomography (CT) and/or positron emission tomography/CT (PET/CT) performed in patients with presumably resectable PM who underwent surgery. Measurements of maximum and sum pleural thickness at three levels of the thorax (upper, middle, and lower) were taken and stratified based on the cutpoints provided by the International Association for the Study of Lung Cancer (IASLC). Clinical and radiological features, including clinical-stage, were compared between resectable and unresectable tumors by univariate analysis and logistic regression modeling.
RESULTS: Of 133 patients, 69/133 (52%) had resectable and 64/133 (48%) had unresectable PM. Asbestos exposure (p = 0.005), neoadjuvant treatment (p = 0.001), clinical T-stage (p < 0.0001), all pleural thickness measurements (p < 0.05), pleural thickness pattern (p < 0.0001) and degree (p = 0.033), lung invasion (p = 0.004), extrapleural space obliteration (p < 0.0001), extension to subphrenic space (p = 0.0004), and two combination variables representing extensive diaphragmatic contact and/or chest wall involvement (p = 0.002) and mediastinal invasion (p < 0.0001) were significant predictors at univariate analysis. At multivariable analysis, all models achieved a strong diagnostic performance (area under the curve (AUC) > 0.8). The two best-performing models were one that included the upper-level maximum pleural thickness, extrapleural space obliteration, and mediastinal infiltration (AUC = 0.876), and another that integrated clinical variables and radiological assessment through the clinical T-stage (AUC = 0.879).
CONCLUSIONS: Selected clinical and radiologic features, including pleural thickness measurements, appear to be strong predictors of unresectability in PM.
CONCLUSIONS: A more accurate prediction of unresectability in the preoperative assessment of patients with pleural mesothelioma may avoid unnecessary surgery and prompt initiation of nonsurgical treatments.
CONCLUSIONS: About half of pleural mesothelioma patients are reported to receive an incorrect disease stage preoperatively. Eleven features identified as predictors of unresectability were included in strongly performing predictive models. More accurate preoperative staging will help clinicians and patients choose the most appropriate treatments.
方法:对手术可能可切除的PM患者的术前计算机断层扫描(CT)和/或正电子发射断层扫描/CT(PET/CT)进行回顾性评估。测量胸部三个水平的最大和总胸膜厚度(上,中间,和更低)根据国际肺癌研究协会(IASLC)提供的切点进行分层。临床和放射学特征,包括临床阶段,通过单因素分析和逻辑回归模型比较可切除和不可切除的肿瘤。
结果:在133名患者中,69/133(52%)可切除,64/133(48%)不可切除的PM。石棉暴露(p=0.005),新辅助治疗(p=0.001),临床T分期(p<0.0001),所有胸膜厚度测量值(p<0.05),胸膜厚度模式(p<0.0001)和程度(p=0.033),肺浸润(p=0.004),胸膜外间隙闭塞(p<0.0001),扩展到次膈空间(p=0.0004),在单变量分析中,代表广泛膈肌接触和/或胸壁受累(p=0.002)和纵隔侵犯(p<0.0001)的两个组合变量是显著的预测因子。在多变量分析中,所有模型均实现了较强的诊断性能(曲线下面积(AUC)>0.8).两个表现最好的模型是包括最高水平最大胸膜厚度的模型,胸膜外间隙闭塞,和纵隔浸润(AUC=0.876),另一个通过临床T分期整合临床变量和放射学评估(AUC=0.879)。
结论:选定的临床和放射学特征,包括胸膜厚度测量,似乎是PM不可切除的有力预测因素。
结论:在胸膜间皮瘤患者的术前评估中更准确的不可切除性预测可能避免不必要的手术和及时启动非手术治疗。
结论:据报道,大约一半的胸膜间皮瘤患者术前出现了不正确的疾病阶段。被确定为不可切除性预测因素的11个特征被包括在强有力的预测模型中。更准确的术前分期将有助于临床医生和患者选择最合适的治疗方法。